Data from The Cancer Genome Atlas (TCGA) further indicate that LDLR expression is more prevalent in both the Mesenchymal and Classical subtypes of GBM, highlighting its potential role in tumor aggressiveness and overall survival (Fig. 1). This evidence concerns the gene LDLR and glioblastoma.